Bioequivalence of Felodipine Controlled Release vs Plendil in Healthy Fasting Subjects

Phase 1, randomised, open-label trial of felodipine in hypertension (HTN) (2 arms), sponsored by Overseas Pharmaceuticals. Primary endpoints: Area under the curve from time zero to the time of the last quantifiable plasma concentration at 1 month, Area under the curve from time zero to infinity at 1 month and 1 more. Status: unknown.